Trials / Completed
CompletedNCT00679718
A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution vs. Placebo in Patients With Moderate to Severe Dry Eye Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
To evaluate the efficacy and safety of INS365 Ophthalmic Solution when applied topically in patients with moderate to severe dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | diquafosol tetrasodium (INS365) ophthalmic solution |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2000-07-01
- Completion
- 2000-07-01
- First posted
- 2008-05-19
- Last updated
- 2015-08-27
Source: ClinicalTrials.gov record NCT00679718. Inclusion in this directory is not an endorsement.